YAP1 and colorectal cancer: In addition to promoting metastasis, the DDX3X-induced YAP1/SIX2 axis might be responsible for resistance to treatment with the anti-EGFR antibody cetuximab (CTX) in colorectal cancer harbouring wild-type KRAS via enhanced autophagy and anti-apoptotic mechanisms [128].